CLEVELAND, Aug. 10, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ technologies and delivering related services for the clinical trials industry, today announced it signed a five-year global agreement with the worldwide leader in medical device research. Under the agreement, the company will use the full software suite from the DATATRAK ONE UX™ platform.
"Our newest partner has recognized the transformative power of our unified dClinical™ platform," said Laurence P. Birch, Chairman and CEO, DATATRAK. "We are pleased that a trusted industry leader, with a reputation for innovation and quality, selected our platform."
"This client is particularly impressed with our next generation CTMS solution, UX CTMS 360™. This solution exemplifies the power of our unified platform. With all data in one location, real-time around the globe, greater business and trial efficiency is at their fingertips."
"Like all of our users, this partner will realize the immediate value of how we simplify clinical research," continued Birch. "Increasing the ability to make informed decisions faster delivers real gains in efficiency. With our industry-leading reporting capability, within and across trials, users can more actively manage their research. That means improved productivity of trial resources. Additional benefits include enhanced patient safety, better site compliance, and increased data quality. There is a difference in a truly unified platform, like DATATRAK ONE UX™, compared to other solutions that claim to be unified - as this competitive takeaway exemplifies."
"As we have communicated over the past few quarters, our strategy and resources are focused on pursuing these long-term, Enterprise Agreement opportunities so that we can build a more stable long-term revenue stream. As we continue to sign these long-term agreements, our business will continue to strengthen and the sophistication of our client base will continue to grow."
"We are proud to welcome this global leader to DATATRAK and are committed to delivering an exceptional customer experience," concluded Birch.
DATATRAK is a worldwide technology and consulting company delivering digital clinical solutions and related services for the clinical trials industry. The company delivers a portfolio of software solutions through the unified dClinical™ platform, safely accelerating clinical research, from Concept to Cure®.
Join DATATRAK Thought Leaders:
Tweet: Global medical device leader selects DATATRAK for multi-year global agreement http://ow.ly/QEAZN
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified dClinical™ solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Chicago, Illinois; Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina; and Plymouth, Minnesota. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full-year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.